Nuestro grupo organiza más de 3000 Series de conferencias Eventos cada año en EE. UU., Europa y América. Asia con el apoyo de 1.000 sociedades científicas más y publica más de 700 Acceso abierto Revistas que contienen más de 50.000 personalidades eminentes, científicos de renombre como miembros del consejo editorial.
Revistas de acceso abierto que ganan más lectores y citas
700 revistas y 15 000 000 de lectores Cada revista obtiene más de 25 000 lectores
Snehal S Manekar, Ravindrakumar L Bakal, Ankush R Turankar
Aim of study: Dengue virus (DENV) causes a clinical infection called dengue hemorrhagic fever (DHF). Millions of people are impacted by this condition. However, there is currently no specific medication available to stop it. Despite having recently received approval for use in preventing illness, a vaccination against some dengue virus (DENV) serotypes was proven to be ineffective. Some preventative methods utilizing plant extracts demonstrated some encouraging ovicidal action against Aedes aegypti.
Summary: Some antiviral medications are being tested in clinical settings to treat dengue fever, but the results have not yet been reported or validated. Numerous researches have revealed that the possibility of using compounds with plant origins could be excellent agents for the creation of secure and effective treatments for certain illnesses. This review provides scientifically validated knowledge on plants used in the treatment and management of dengue fever along with phytoconstituents responsible for the activity and type of solvent used to extract it.